Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus‐Cruces‐Bordeaux Inception Cohort

Author:

Ruiz‐Irastorza Guillermo1ORCID,Paredes‐Ruiz Diana2ORCID,Herrero‐Galvan Maria3,Moreno‐Torres Victor4ORCID,Hernandez‐Negrin Halbert5ORCID,Ruiz‐Arruza Ioana1ORCID,Leonard Cedric6,Richez Christophe6ORCID,Lazaro Estibaliz6ORCID

Affiliation:

1. Biobizkaia Health Research Institute and University of The Basque Country‐UPV/EHU Bizkaia Basque Country Spain

2. Biobizkaia Health Research Institute Bizkaia Basque Country Spain

3. University of The Basque Country‐UPV/EHU Bizkaia Basque Country Spain

4. Hospital Universitario Cruces, Bizkaia, Basque Country, UNIR Health Sciences School and Hospital Universitario Puerta de Hierro Majadahonda Madrid Spain

5. Hospital Universitario Cruces, Bizkaia, Basque Country, Hospital Regional Universitario de Málaga and Universidad de Málaga Málaga Spain

6. Bordeaux Hospital University Bordeaux France

Abstract

ObjectiveThe objective of this study was to analyze the effect of methylprednisolone pulses (MP), given during the first year after the diagnosis of systemic lupus erythematosus (SLE), in achieving prolonged remission according to the degree of lupus activity at presentation.MethodsWe conducted an observational study of routine clinical care data from the Lupus‐Cruces‐Bordeaux cohort. The end point was prolonged remission (ie, during five consecutive yearly visits). The effect of MP on remission during the first year was analyzed in the whole cohort and according to the baseline Systemic Lupus Erythematosus Disease Activity Index 2000 score: <6, 6 to 12, and >12, reflecting mild, moderate, and severe activity, respectively. For adjustment, logistic regression with propensity score (PS) and other therapeutic covariates was performed.ResultsTwo hundred thirty‐three patients were included. Prolonged remission was achieved by 132 patients (57%). MP were associated with prolonged remission (PS‐adjusted odds ratio [OR] 2.50, 95% confidence interval [CI] 1.04–623, P = 0.042). A strong clinical effect was seen among patients with moderate (adjusted OR 5.28, 95% CI 1.27–21.97, P = 0.022) and moderate‐severe SLE activity (adjusted OR 4.07, 95% CI 1.11–14.82, P = 0.033). The administration of MP resulted in reduced average dosages of prednisone during the first year among patient with moderate (mean 6.6 vs 10.2 mg/day, P = 0.017) and severe activity (mean 14 vs 28 mg/day, P = 0.015). The odds of prolonged remission were increased by longer‐term use of hydroxychloroquine (HCQ) and decreased by higher initial doses of prednisone.ConclusionThis study supports the use of MP to induce prolonged remission in patients with SLE, particularly in those with moderate and severe activity. The extended use of HCQ also contributes to achieve prolonged remission.image

Funder

Hezkuntza, Hizkuntza Politika Eta Kultura Saila, Eusko Jaurlaritza

Consejería de Transformación Económica, Industria, Conocimiento y Universidades

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3